Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen A-M, Ahonen R, Hartikainen S

J Alzheimers Dis. 2017; 56(1):107-118. PMID: 27935554. Abstract